Constipation Solution for Renal Patients: Elobixibat Boosts Bowel Health with Proven Safety

Constipation Solution for Renal Patients: Elobixibat Boosts Bowel Health with Proven Safety, Bixibat, Docvidya, Constipation Management, General Practice, General Practitioner, Gastroenterology, Gastroenterologist, Consultant Physician, Elobixibat, CKD Patients, Chronic Constipation, lipid metabolism.

goal To investigate the effects of elobixibat on constipation and lipid metabolism and determine the factors associated with the effect of elobixibat on constipation in patients with moderate to end-stage CKD

BUN: Blood urea nitrogen; CKD: Chronic kidney disease; eGFR: Estimated glomerular filtration rate; HbA1c: Glycated hemoglobin; HDL-C: High-density lipoprotein cholesterol; LDL-C: Low-density lipoprotein cholesterol; SBM: Spontaneous bowel movement.
Reference: Matsuyama M, Hirai K, Nonaka H, et al. Effects of Elobixibat on constipation and lipid metabolism in patients with moderate to end-stage chronic kidney disease. Front Med (Lausanne). 2022;8:780127.

For the use of a Registered Medical Practitioner, Hospital or a Laboratory only. GGI-CO-A1-AQS-300041570-ELC-J24-1192

Bixibat

BixiBat: A Revolutionary Elobixibat-Based Drug for Effective Chronic Constipation Treatment

Know more

Constipation Solution for Renal Patients: Elobixibat Boosts Bowel Health with Proven Safety

Related Articles

Login to continue